Stockscreener 앱 받기
7.52
7.43%
0.52
시간 외 거래:
7.59
0.07
+0.93%
전일 마감가:
$7.00
열려 있는:
$7.04
하루 거래량:
542.62K
Relative Volume:
1.82
시가총액:
$424.39M
수익:
-
순이익/손실:
$-72.89M
주가수익비율:
-3.1074
EPS:
-2.42
순현금흐름:
$-68.47M
1주 성능:
+21.68%
1개월 성능:
+7.12%
6개월 성능:
+20.71%
1년 성능:
-34.49%
1일 변동 폭
$6.84
$7.57
1주일 범위
$6.22
$7.57
52주 변동 폭
$3.555
$12.92
Astria Therapeutics Inc Stock (ATXS) Company Profile
명칭
Astria Therapeutics Inc
전화
617-349-1971
주소
22 BOSTON WHARF ROAD, BOSTON
ATXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
7.52 | 395.04M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-31 | 개시 | JMP Securities | Mkt Outperform |
| 2024-07-29 | 개시 | TD Cowen | Buy |
| 2023-03-28 | 개시 | Evercore ISI | Outperform |
Astria Therapeutics Inc 주식(ATXS)의 최신 뉴스
Astria Therapeutics, Inc. $ATXS Shares Purchased by Hsbc Holdings PLC - Defense World
Is Astria Therapeutics Inc. stock forming a cup and handleJuly 2025 Review & Low Risk High Reward Trade Ideas - خودرو بانک
Has Astria Therapeutics Inc. formed a bullish divergence2025 Analyst Calls & Technical Pattern Alert System - Newser
Will Astria Therapeutics Inc. outperform its industry peersJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - خودرو بانک
Does Astria Therapeutics Inc. have strong EBITDA marginsPortfolio Gains Report & Daily Growth Stock Tips - خودرو بانک
What to expect from Astria Therapeutics Inc. in the next 30 daysDividend Hike & Stepwise Trade Execution Plans - Newser
Can Astria Therapeutics Inc. maintain its current growth rate2025 Top Gainers & Verified Short-Term Plans - خودرو بانک
What machine learning models say about Astria Therapeutics Inc.Trade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Astria Therapeutics (ATXS): Strategic Advancements and Clinical Catalysts in 2025 Position the Biotech for Strong Shareholder Value - AInvest
Astria Therapeutics: A High-Conviction Biotech Play in Rare Diseases and Immune Disorders - AInvest
Transcript : Astria Therapeutics, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 03 - MarketScreener
Astria Therapeutics Inc. stock daily chart insights2025 Fundamental Recap & Real-Time Market Sentiment Alerts - Newser
Does Astria Therapeutics Inc. have pricing power2025 Technical Patterns & Daily Growth Stock Investment Tips - خودرو بانک
Astria Therapeutics at Cantor Conference: Strategic Program Insights By Investing.com - Investing.com Canada
Astria Therapeutics Inc. stock volume spike explained2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
Astria Therapeutics at Cantor Conference: Strategic Program Insights - Investing.com
Astria Therapeutics shares fall 3.58% intraday after announcing inducement grants. - AInvest
What machine learning models say about Astria Therapeutics IncSwing Trade & Free Weekly Watchlist of Top Performers - Newser
Astria Therapeutics Inc. stock trend forecastPortfolio Profit Report & Fast Gain Swing Alerts - Newser
103,517 Shares in Astria Therapeutics, Inc. $ATXS Acquired by Nuveen LLC - Defense World
Is Astria Therapeutics Inc. stock poised for growth2025 Performance Recap & Risk Controlled Daily Plans - Newser
Detecting support and resistance levels for Astria Therapeutics Inc.Portfolio Return Report & Consistent Income Trade Ideas - Newser
Can Astria Therapeutics Inc. expand into new marketsMarket Sentiment Report & Verified Short-Term Plans - خودرو بانک
Astria Therapeutics’ Strategic Use of Equity Incentives: A Catalyst for Talent Retention and Innovation in a High-Stakes Biotech Landscape? - AInvest
Astria Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Astria Therapeutics shares rise 3.26% intraday after announcing Phase 1a trial data presentation at EADV Congress 2025. - AInvest
Astria Therapeutics to present STAR-0310 phase 1a data at EADV congress - Investing.com
Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025 - Yahoo Finance
What does recent volatility data suggest for Astria Therapeutics Inc.Chart Signals & Stepwise Swing Trade Plans - Newser
Can Astria Therapeutics Inc. disrupt its industryCEO Change & Fast Exit Strategy with Risk Control - khodrobank.com
Trading Recap: Is Astria Therapeutics Inc. in a bullish channelBull Run & Safe Capital Growth Tips - خودرو بانک
Technical analysis overview for Astria Therapeutics Inc. stockJuly 2025 Setups & Verified Technical Signals - Newser
Visual trend scoring systems applied to Astria Therapeutics Inc.2025 Trading Volume Trends & Risk Managed Trade Strategies - Newser
Key metrics from Astria Therapeutics Inc.’s quarterly dataWall Street Watch & Expert Curated Trade Setups - Newser
Is Astria Therapeutics Inc. forming a bottoming baseQuarterly Portfolio Summary & Intraday High Probability Alerts - Newser
Astria Therapeutics, Inc. $ATXS Shares Purchased by Wellington Management Group LLP - Defense World
What earnings revisions data tells us about Astria Therapeutics Inc.July 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Charles Schwab Investment Management Inc. Sells 7,560 Shares of Astria Therapeutics, Inc. $ATXS - Defense World
Visual trend scoring systems applied to Astria Therapeutics IncWall Street Watch & Weekly Top Gainers Trade List - Newser
Applying Elliott Wave Theory to Astria Therapeutics Inc.Market Performance Report & High Accuracy Trade Alerts - Newser
Astria Therapeutics Inc (ATXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):